Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
1,3-DISUBSTITUTED HETEROARYL NMDA/NR2B ANTAGONISTS
Document Type and Number:
WIPO Patent Application WO2006017409
Kind Code:
A3
Abstract:
Compounds represented by Formula I: (wherein A, B, D, P, Q, R1, R2, R3, W and Y are described herein) or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke, and other conditions.

Inventors:
LAYTON MARK E (US)
RODZINAK KEVIN J (US)
KELLY MICHAEL J III (US)
SANDERSON PHILIP E (US)
Application Number:
US2005027160W
Publication Date:
November 30, 2006
Filing Date:
July 29, 2005
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MERCK & CO INC (US)
LAYTON MARK E (US)
RODZINAK KEVIN J (US)
KELLY MICHAEL J III (US)
SANDERSON PHILIP E (US)
International Classes:
C07D487/04; A61K31/519; C07C233/09; C07C249/04; C07C255/34; C07D207/50; C07D249/02; C07D249/18; C07D263/32; C07D271/02; C07D277/28; C07D285/01; C07D315/00
Foreign References:
US20050197340A12005-09-08
US20050054658A12005-03-10
US20050059650A12005-03-17
US4904666A1990-02-27
Other References:
See also references of EP 1797094A4
Download PDF: